Tetrahydro-1H-oxazolo[3,4-a]pyrazin-3(5H)-one hydrochloride
97%
- Product Code: 53080
CAS:
1020349-31-8
| Molecular Weight: | 178.6200 g./mol | Molecular Formula: | C₆H₁₁ClN₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD09878828 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. It serves as a key intermediate in the creation of biologically active molecules, often targeting neurological and psychiatric disorders. Its structural framework is valuable in designing compounds that interact with specific receptors or enzymes in the central nervous system, potentially leading to treatments for conditions such as anxiety, depression, or cognitive impairments. Additionally, it may be explored in medicinal chemistry for its potential to enhance drug efficacy and selectivity. Researchers also investigate its role in modulating biochemical pathways, contributing to the development of innovative therapeutic agents.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | £116.03 |
+
-
|
Tetrahydro-1H-oxazolo[3,4-a]pyrazin-3(5H)-one hydrochloride
This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. It serves as a key intermediate in the creation of biologically active molecules, often targeting neurological and psychiatric disorders. Its structural framework is valuable in designing compounds that interact with specific receptors or enzymes in the central nervous system, potentially leading to treatments for conditions such as anxiety, depression, or cognitive impairments. Additionally, it may be explored in medicinal chemistry for its potential to enhance drug efficacy and selectivity. Researchers also investigate its role in modulating biochemical pathways, contributing to the development of innovative therapeutic agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :